Executive General Manager Commercialisation and Research Contracts, Baker Heart and Diabetes Institute

Dr Guy Krippner is currently Exec GM Commercialisation and Research Contracts at the Baker Institute. He has 15 years of experience as a senior Medicinal Chemist within the Biotechnology industry; 7 years of which have been as Head of Medicinal Chemistry within three different organisations.

He has participated in and managed a diverse range of drug discovery and development projects at Biota Holdings, Prana Biotechnology Ltd Starpharma Ltd and Verva Pharmaceuticals Ltd and is currently responsible for Commercialisation of the Baker Institute's research activities.

Dr Krippner is an inventor on 11 patent families.

Experience

  • 2008–present
    Head of Medicinal Chemistry, Baker IDI

Education

  • 1990 
    University of Adelaide, PhD